Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan.
Department of Neurosurgery, JA Onomichi General Hospital, Onomichi, Japan.
World Neurosurg. 2021 Apr;148:e459-e470. doi: 10.1016/j.wneu.2021.01.001. Epub 2021 Jan 11.
Asymptomatic or minor symptom meningiomas (AMSMs) in the elderly are incidental findings, with no consensus reached on the optimal management strategy. In the present study, we aimed to determine the surgical risk factors for elderly patients with AMSMs using a nationwide registry database in Japan.
We identified patients with surgically treated AMSMs using the Diagnosis Procedure Combination database from 2010 to 2015 and reviewed the medical records for age (<65 years; pre-elderly, 65-74 years; and elderly, ≥75 years), sex, Barthel index (BI) score, medical history, tumor location, and complications. An AMSM was defined by a BI score of 100 points at admission. The risk factors for all stroke complications, BI deterioration at discharge, and in-hospital mortality were determined using multivariate logistic regression analyses.
From a total of 10,535 patients with meningioma, 6628 were included. Advanced age was a significant risk factor (odds ratio, 3.54; 95% confidence interval, 2.80-4.46) for BI deterioration but not for all-stroke complications or in-hospital mortality. Midline and posterior fossa tumors, diabetes mellitus, and chronic heart disease were significant risk factors for in-hospital mortality.
For elderly patients with surgically treated AMSMs, advanced age was a prominent risk factor for functional decline at discharge. Our study identified several factors that should be evaluated before proceeding with surgery for AMSMs in elderly and pre-elderly patients. These findings could, not only improve decision-making among clinicians treating patients with AMSMs, but also help in predicting the results of surgery for elderly patients with AMSMs.
老年人无症状或症状轻微的脑膜瘤(AMSMs)是偶然发现的,对于最佳治疗策略尚未达成共识。本研究旨在使用日本全国注册数据库确定老年 AMSMs 患者的手术风险因素。
我们使用 2010 年至 2015 年的诊断程序组合数据库确定了接受手术治疗的 AMSMs 患者,并回顾了他们的病历,包括年龄(<65 岁;年轻老年人,65-74 岁;老年人,≥75 岁)、性别、巴氏指数(BI)评分、病史、肿瘤位置和并发症。入院时 BI 评分为 100 分的患者被定义为 AMSM。使用多变量逻辑回归分析确定所有中风并发症、出院时 BI 恶化和住院期间死亡率的风险因素。
在总共 10535 名脑膜瘤患者中,有 6628 名患者被纳入研究。高龄是 BI 恶化的显著风险因素(优势比,3.54;95%置信区间,2.80-4.46),但不是所有中风并发症或住院期间死亡率的风险因素。中线和后颅窝肿瘤、糖尿病和慢性心脏病是住院期间死亡的显著风险因素。
对于接受手术治疗的老年 AMSMs 患者,高龄是出院时功能下降的显著风险因素。本研究确定了一些因素,这些因素应在对老年和年轻老年人的 AMSMs 进行手术前进行评估。这些发现不仅可以改善治疗 AMSMs 患者的临床医生的决策,还可以帮助预测老年 AMSMs 患者手术的结果。